|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
DETREND PRICE OSCILLARTOR
Trading: BUY @ $0.15
Signal Strength: STRONG
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.
Impedimed (ASX:IPD) currently has a confirmed uptrend. Price is currently above the displaced moving average for IPD Currently, the return on DPO20 is -3.2%.
The Detrended Price Oscillator (DPO) is an indicator designed to remove trend from price and make it easier to identify cycles. DPO does not extend to the last date because it is based on a displaced moving average. However alignment with the most recent is not an issue because DPO is not a momentum oscillator. Instead DPO is used to identify cycle’s highs/lows and estimate cycle length.
Calculation: Detrended Price Oscillator (DPO):
1) Price (X/2 + 1) periods ago minus X-period simple moving average.
Where X is the number of periods;
PROFILE: Impedimed (IPD.AX)
Stock Exchange: ASX
Ticker Codes: | IPD.AX | ASX:IPD |
ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
|MOY Millennium Minerals||0.13||13.6||1,861,319||0.03||BULLISH|
|ONE Oneview Healthcare||0.29||11.8||184,305||0.05||BULLISH|
|MXI Maxitra Industries||0.33||8.2||24,282||0.03||BULLISH|
|SLR Silver Lake Resources||1.45||8.2||9,252,383||0.53||BULLISH|
|RSG Resolute Mining||1.74||7.1||9,161,059||0.61||BULLISH|
|PRU Perseus Mining||0.71||6.8||12,414,565||0.22||BULLISH|
|AQG Alacer Gold Corp||5.42||6.3||936,317||1.21||BULLISH|
|NST Northern Star Resources||13.47||6||4,840,454||3.38||BULLISH|
|WAF West African Resources||0.39||5.4||3,897,020||0.09||BULLISH|
|SBM St Barbara Mines||3.55||5.3||5,019,351||0.6||BULLISH|